Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production

Journal of Cell Biology

Volumn 190, Issue 6, 2010, Pages 1093-1106

  Bozec, Aline ^a   Bakiri, Latifa ^a   Jimenez, Maria ^a   Schinke, Thorsten ^b   Amling, Michael ^b   Wagner, Erwin F ^a  

^a BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN 1ALPHA2; OSTEOCALCIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ALPHA 2(I) COLLAGEN; COLLAGEN TYPE 1; FOSL2 PROTEIN, HUMAN; FOSL2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR FRA 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; IN VITRO SELECTION; IN VIVO STUDY; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOSARCOMA; OSTEOSCLEROSIS; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BONE DEVELOPMENT; BONE MATRIX; COMPLICATION; DEFICIENCY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; KNOCKOUT MOUSE; METABOLIC BONE DISEASE; METABOLISM; PATHOLOGY; PHENOTYPE;

MURINAE; MUS;

ANIMALS; BONE DISEASES, METABOLIC; BONE MATRIX; CELL DIFFERENTIATION; COLLAGEN; COLLAGEN TYPE I; FOS-RELATED ANTIGEN-2; GENE EXPRESSION REGULATION; HUMANS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; OSTEOSCLEROSIS; PHENOTYPE; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 77957189890     PISSN: 00219525     EISSN: 00219525     Source Type: Journal    
DOI: 10.1083/jcb.201002111     Document Type: Article

References (45)

1. Bakiri, L., K. Matsuo, M. Wisniewska, E.F. Wagner, and M. Yaniv. 2002. Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22:4952-4964. doi:10.1128/MCB.22.13.4952-4964.2002
2. Behrens, A., J. Haigh, F. Mechta-Grigoriou, A. Nagy, M. Yaniv, and E.F. Wagner. 2003. Impaired intervertebral disc formation in the absence of Jun. Development. 130:103-109. doi:10.1242/dev.00186
3. Boskey, A.L. 1998. Biomineralization: conflicts, challenges, and opportunities. J. Cell. Biochem. Suppl. 72:83-91. doi:10.1002/(SICI)1097- 4644(1998)72:30/31+〈83::AID-JCB12〉3.0.CO;2-F
4. Bozec, A., L. Bakiri, A. Hoebertz, R. Eferl, A.F. Schilling, V. Komnenovic, H. Scheuch, M. Priemel, C.L. Stewart, M. Amling, and E.F. Wagner. 2008. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia. Nature. 454:221-225. doi:10.1038/nature07019
5. Bruserud, O., K.J. Tronstad, and R. Berge. 2005. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J. Cancer Res. Clin. Oncol. 131:377-384. doi:10.1007/s00432-004-0650-z
6. Chang, E., and H. Goldberg. 1995. Requirements for transforming growth factor-beta regulation of the pro-alpha 2(I) collagen and plasminogen activator inhibitor-1 promoters. J. Biol. Chem. 270:4473-4477. doi:10.1074/jbc.270.9.4473
7. Chien, K.R., and G. Karsenty. 2005. Longevity and lineages: toward the integrative biology of degenerative diseases in heart, muscle, and bone. Cell. 120:533-544. doi:10.1016/j.cell.2005.02.006
8. Chung, K.Y., A. Agarwal, J. Uitto, and A. Mauviel. 1996. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J. Biol. Chem. 271:3272-3278. doi:10.1074/jbc.271.6.3272
9. David, J.P., K. Sabapathy, O. Hoffmann, M.H. Idarraga, and E.F. Wagner. 2002. JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation- dependent and -independent mechanisms. J. Cell Sci. 115:4317-4325. doi:10.1242/jcs.00082
10. Ducy, P., and G. Karsenty. 1995. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol. Cell. Biol. 15:1858-1869.
11. Ducy, P., C. Desbois, B. Boyce, G. Pinero, B. Story, C. Dunstan, E. Smith, J. Bonadio, S. Goldstein, C. Gundberg, et al. 1996a. Increased bone formation in osteocalcin-deficient mice. Nature. 382:448-452. doi:10.1038/382448a0
12. Ducy, P., V. Geoffroy, and G. Karsenty. 1996b. Study of osteoblast-specific expression of one mouse osteocalcin gene: characterization of the factor binding to OSE2. Connect. Tissue Res. 35:7-14. doi:10.3109/03008209609029169
13. Eferl, R., A. Hoebertz, A.F. Schilling, M. Rath, F. Karreth, L. Kenner, M. Amling, and E.F. Wagner. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23:2789-2799. doi:10.1038/sj.emboj.7600282
14. Eferl, R., R. Zenz, H.C. Theussl, and E.F. Wagner. 2007. Simultaneous generation of fra-2 conditional and fra-2 knock-out mice. Genesis. 45:447-451. doi:10.1002/dvg.20311
15. Eferl, R., P. Hasselblatt, M. Rath, H. Popper, R. Zenz, V. Komnenovic, M.H. Idarraga, L. Kenner, and E.F. Wagner. 2008. Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1. Proc. Natl. Acad. Sci. USA. 105:10525-10530. doi:10.1073/pnas.0801414105
16. Elefteriou, F., J.D. Ahn, S. Takeda, M. Starbuck, X. Yang, X. Liu, H. Kondo, W.G. Richards, T.W. Bannon, M. Noda, et al. 2005. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature. 434:514-520. doi:10.1038/nature03398
17. Enomoto, H., T. Furuichi, A. Zanma, K. Yamana, C. Yoshida, S. Sumitani, H. Yamamoto, M. Enomoto-Iwamoto, M. Iwamoto, and T. Komori. 2004. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro. J. Cell Sci. 117:417-425. doi:10.1242/jcs.00866
18. Fox, C., Z.S. Husain, M.B. Shah, D.R. Lucas, and H.A. Saleh. 2009. Chondroblastic osteosarcoma of the cuboid: a literature review and report of a rare case. J. Foot Ankle Surg. 48:388-393. doi:10.1053/j.jfas.2009.02.004
19. Goldberg, H., T. Helaakoski, L.A. Garrett, G. Karsenty, A. Pellegrino, G. Lozano, S. Maity, and B. de Crombrugghe. 1992. Tissue-specific expression of the mouse alpha 2(I) collagen promoter. Studies in transgenic mice and in tissue culture cells. J. Biol. Chem. 267:19622-19630.
20. Grigoriadis, A.E., K. Schellander, Z.Q. Wang, and E.F. Wagner. 1993. Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122:685-701. doi:10.1083/jcb.122.3.685
21. Hinoi, E., N. Gao, D.Y. Jung, V. Yadav, T. Yoshizawa, M.G. Myers Jr., S.C. Chua Jr., J.K. Kim, K.H. Kaestner, and G. Karsenty. 2008. The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183:1235-1242. doi:10.1083/jcb.200809113
22. Hinoi, E., N. Gao, D.Y. Jung, V. Yadav, T. Yoshizawa, D. Kajimura, M.G. Myers Jr., S.C. Chua Jr., Q. Wang, J.K. Kim, et al. 2009. An Osteoblast-dependent mechanism contributes to the leptin regulation of insulin secretion. Ann. NY Acad. Sci. 1173(Suppl 1):E20-E30. doi:10.1111/j.1749-6632. 2009.05061.x
23. Jochum, W., J.P. David, C. Elliott, A. Wutz, H. Plenk Jr., K. Matsuo, and E.F. Wagner. 2000. Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6:980-984. doi:10.1038/79676
24. Julien, M., S. Khoshniat, A. Lacreusette, M. Gatius, A. Bozec, E.F. Wagner, Y. Wittrant, M. Masson, P. Weiss, L. Beck, et al. 2009. Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J. Bone Miner. Res. 24:1856-1868. doi:10.1359/jbmr.090508
25. Karreth, F., A. Hoebertz, H. Scheuch, R. Eferl, and E.F. Wagner. 2004. The AP1 transcription factor Fra2 is required for efficient cartilage development. Development. 131:5717-5725. doi:10.1242/dev.01414
26. Karsenty, G., and R.W. Park. 1995. Regulation of type I collagen genes expression. Int. Rev. Immunol. 12:177-185. doi:10.3109/08830189509056711
27. Karsenty, G., and E.F. Wagner. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell. 2:389-406. doi:10.1016/ S1534-5807(02)00157-0
28. Kawamata, A., Y. Izu, H. Yokoyama, T. Amagasa, E.F. Wagner, K. Nakashima, Y. Ezura, T. Hayata, and M. Noda. 2008. JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion. J. Cell. Biochem. 103:1037-1045. doi:10.1002/jcb.21660
29. Kenner, L., A. Hoebertz, T. Beil, N. Keon, F. Karreth, R. Eferl, H. Scheuch, A. Szremska, M. Amling, M. Schorpp-Kistner, et al. 2004. Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164:613-623. doi:10.1083/jcb.200308155
30. Kobayashi, H., Y. Gao, C. Ueta, A. Yamaguchi, and T. Komori. 2000. Multilineage differentiation of Cbfa1-deficient calvarial cells in vitro. Biochem. Biophys. Res. Commun. 273:630-636. doi:10.1006/bbrc.2000.2981
31. Kveiborg, M., R. Chiusaroli, N.A. Sims, M. Wu, G. Sabatakos, W.C. Horne, and R. Baron. 2002. The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology. 143:4304-4309. doi:10.1210/en.2002-220420
32. Li, S., and G.P. Siegal. 2010. Small cell tumors of bone. Adv. Anat. Pathol. 17:1-11.
33. Murshed, M., D. Harmey, J.L. Millán, M.D. McKee, and G. Karsenty. 2005. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 19:1093-1104. doi:10.1101/gad.1276205
34. Parfitt, A.M., M.K. Drezner, F.H. Glorieux, J.A. Kanis, H. Malluche, P.J. Meunier, S.M. Ott, and R.R. Recker. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2:595-610. doi:10.1002/jbmr.5650020617
35. Ponticos, M., C. Harvey, T. Ikeda, D. Abraham, and G. Bou-Gharios. 2009. JunB mediates enhancer/promoter activity of COL1A2 following TGF-beta induction. Nucleic Acids Res. 37:5378-5389. doi:10.1093/nar/gkp544
36. Reimold, A.M., M.J. Grusby, B. Kosaras, J.W. Fries, R. Mori, S. Maniwa, I.M. Clauss, T. Collins, R.L. Sidman, M.J. Glimcher, and L.H. Glimcher. 1996. Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature. 379:262-265. doi:10.1038/379262a0
37. Rochet, N., J. Dubousset, C. Mazeau, E. Zanghellini, M.F. Farges, H.S. de Novion, A. Chompret, B. Delpech, N. Cattan, M. Frenay, and J. Gioanni. 1999. Establishment, characterisation and partial cytokine expression pro- file of a new human osteosarcoma cell line (CAL 72). Int. J. Cancer. 82: 282-285. doi:10.1002/(SICI)1097-0215(19990719)82:2〈282::AID-IJC20〉 3.0.CO;2-R
38. Rochet, N., P. Leroy, D.F. Far, L. Ollier, A. Loubat, and B. Rossi. 2003. CAL72: a human osteosarcoma cell line with unique effects on hematopoietic cells. Eur. J. Haematol. 70:43-52. doi:10.1034/j.1600-0609.2003.02766.x
39. Rodan, G.A., and T.J. Martin. 2000. Therapeutic approaches to bone diseases. Science. 289:1508-1514. doi:10.1126/science.289.5484.1508
40. Sabatakos, G., N.A. Sims, J. Chen, K. Aoki, M.B. Kelz, M. Amling, Y. Bouali, K. Mukhopadhyay, K. Ford, E.J. Nestler, and R. Baron. 2000. Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6:985-990. doi:10.1038/79683
41. Takeda, S., and G. Karsenty. 2008. Molecular bases of the sympathetic regulation of bone mass. Bone. 42:837-840. doi:10.1016/j.bone.2008.01.005
42. Teitelbaum, S.L., and F.P. Ross. 2003. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4:638-649. doi:10.1038/nrg1122
43. Wagner, E.F., and R. Eferl. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208:126-140. doi:10.1111/j.0105-2896.2005.00332.x
44. Wu, Z., Y. Xie, N.L. Bucher, and S.R. Farmer. 1995. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 9:2350-2363. doi:10.1101/gad.9.19.2350
45. Yang, X., K. Matsuda, P. Bialek, S. Jacquot, H.C. Masuoka, T. Schinke, L. Li, S. Brancorsini, P. Sassone-Corsi, T.M. Townes, et al. 2004. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 117:387-398. doi:10.1016/S0092-8674(04)00344-7